Novel Mitochondrial Ion Transporters

新型线粒体离子转运蛋白

• 批准号: 8676919
• 负责人: Brian O'Rourke
• 金额: $ 45.51万
• 依托单位: JOHNS HOPKINS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-08-15 至 2016-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8676919
• 关键词: ATP Synthesis Pathway; Anions; Area; Arrhythmia; Bioenergetics; Biological Assay; CLIC4 gene; Calcium; Calcium-Activated Potassium Channel; Cardiac; Carrier Proteins; Cations; Cell Death; Cell model; Cells; Cystic Fibrosis Transmembrane Conductance Regulator; Equilibrium; Fractionation; Functional disorder; Funding; GABA Receptor; Goals; Heart; Homeostasis; Hydrogen; Inner mitochondrial membrane; Ion Channel; Ion Transport; Ions; Ischemia; KCNJ1 gene; Learning; Link; Mass Spectrum Analysis; Mediating; Membrane; Messenger RNA; Mitochondria; Mitochondrial Proteins; Mitochondrial Swelling; Modification; Molecular; Molecular Biology; Monovalent Cations; Movement; Muscle Contraction; Mutagenesis; Oxidants; Oxidation-Reduction; Oxidative Stress; Pathway interactions; Permeability; Physiological; Potassium Channel; Predisposition; Principal Investigator; Process; Production; Protein Family; Proteins; Proteome; Proteomics; Protons; RNA Splicing; Regulation; Reperfusion Injury; Reperfusion Therapy; Reporting; Research; Role; Simulate; Sodium; Stress; Techniques; Tissues; Translations; Variant; Water; Workload; antiporter; base; design; gamma-Aminobutyric Acid; genetic manipulation; inhibitor/antagonist; inward rectifier potassium channel; mitochondrial K(ATP) channel; mitochondrial membrane; novel; overexpression; programs; protein purification; response; tool; trafficking; uptake

DESCRIPTION (provided by applicant): Proton transport across the mitochondrial inner membrane provides the protonmotive force for ATP synthesis, but the importance of the transport of other ions (e.g. K+, Na+, Ca2+, and anions) in the regulation of bioenergetics has become increasingly evident in recent years. Over the past several years, our focus has been on three main areas, i) characterizing the K+ uptake pathways involved in protection against ischemic damage, ii) understanding how Na+ and Ca2+ dynamics impact energy supply and demand balance, and iii) characterizing how inner membrane oxidant-sensitive energy dissipating channels are activated by stress. While much has been learned using pharmacological tools and manipulation of ion gradients in isolated mitochondria, cells, and intact hearts, a major limitation has been the lack of molecular information about the proteins mediating ion transport in the inner membrane. Based on an exhaustive protein purification and fractionation strategy, and the team approach undertaken during the prior funding period designed to fully characterize the mitochondrial proteome and its modifications during ischemia- reperfusion, we have been successful in identifying a number of novel, high confidence candidates that we believe underlie important K+, Na+ and Ca2+ transport pathways in the mitochondrial inner membrane. Intriguingly, we have also identified novel mitochondrial anion transporters that could prove to be involved in the regulation of mitochondrial function. This project will combine molecular techniques for manipulating the expression levels of mitochondrial proteins identified by mass spectrometry with functional assays in isolated mitochondria and cells to correlate a particular ion transport pathway with its corresponding protein. Based on evidence already obtained by mass spectrometry, we believe we are on track to unequivocally resolve the molecular entities comprising the pore forming subunits of the mitochondrial ATP-sensitive (mitoKATP) and calcium-activated (mitoKCa) potassium channels, and are currently pursuing strong candidates that could mediate mitochondrial sodium calcium exchange (mNCE) and monovalent cation-hydrogen exchange (KHE or NHE). We will also investigate the possible functional role of identified, but uncharacterized, anion transporters that may be involved in mitochondrial volume regulation and the response to oxidative stress. The ultimate goal of the project is to overcome a significant roadblock to progress in the area of mitochondrial biology - the molecular identification of ion transport proteins that are critical to normal function and to the pathophysiology of ischemia-reperfusion.

描述（由申请人提供）：质子在线粒体内膜上的转运为ATP合成提供质子动力，但近年来，其他离子（如K+、Na+、Ca2+和阴离子）的转运在生物能量学调节中的重要性越来越明显。在过去的几年中，我们的重点一直集中在三个主要领域，1)表征参与保护缺血性损伤的K+摄取途径，2)了解Na+和Ca2+动态如何影响能量供需平衡，以及3)表征细胞膜氧化敏感的能量耗散通道如何被应激激活。虽然利用药理学工具和对分离的线粒体、细胞和完整心脏中的离子梯度的操作已经了解了很多，但主要的限制是缺乏关于在内膜中介导离子运输的蛋白质的分子信息。基于详尽的蛋白质纯化和分离策略，以及在先前资助期间进行的团队方法，旨在充分表征线粒体蛋白质组及其在缺血-再灌注期间的修饰，我们已经成功地确定了许多新的，高可信度的候选蛋白，我们认为这些候选蛋白是线粒体内膜中重要的K+， Na+和Ca2+运输途径的基础。有趣的是，我们还发现了新的线粒体阴离子转运蛋白，可能被证明参与线粒体功能的调节。该项目将结合分子技术来控制线粒体蛋白的表达水平，通过质谱鉴定，并在分离的线粒体和细胞中进行功能分析，以将特定的离子运输途径与其相应的蛋白质联系起来。基于质谱法已经获得的证据，我们相信我们正在明确地解决由线粒体atp敏感（mitoKATP）和钙激活（mitoKCa）钾通道的孔隙形成亚基组成的分子实体，并且目前正在寻找可能介导线粒体钠钙交换（mNCE）和单价阳离子-氢交换（KHE或NHE）的强有力的候选物质。我们还将研究可能参与线粒体体积调节和氧化应激反应的已确定但未表征的阴离子转运体的功能作用。该项目的最终目标是克服线粒体生物学领域进展的一个重大障碍-离子转运蛋白的分子鉴定，这对正常功能和缺血再灌注的病理生理至关重要。